| 5-ASA | 5-aminosalicylic acid |
| AA | Arachidonic acid |
| AE | Adverse event |
| ALA | α-linolenic acid |
| CD | Crohn’s disease |
| CI | Confidence interval |
| COX | Cyclooxygenase |
| CDAI | Crohn’s Disease Activity Index |
| CRP | C reactive protein |
| DHA | Docosahexaenoic acid |
| DPA | Docosapentaenoic acid |
| EET | Epoxyeicosatrienoic acid |
| ELOVL | Elongase of very long chain fatty acids |
| EPA | Eicosapentaenoic acid |
| EPIC | European Prospective Investigation into Cancer and Nutrition |
| FADS | Fatty acid desaturase |
| FC | Faecal calprotectin |
| FFA | Free fatty acid |
| GLA | n-6 gamma linolenic acid |
| HETEs | Hydroxyeicosatetraenoic acid |
| HR | Hazard ratio |
| IBD | Inflammatory bowel disease |
| IL | Interleukin |
| LA | Linoleic acid |
| LOX | Lipoxygenase |
| LT | Leukotriene |
| LX | Lipoxin |
| MAPK | Mitogen-activated protein kinase |
| NFkβ | Nuclear factor kB |
| NLRs | NOD-like receptors |
| NLRP3 | NOD-like receptor protein 3 |
| NO | Nitric oxide |
| NOD2 | Nucleotide-binding oligomerisation domain 2 |
| NOS | Nitric oxide synthase |
| OA | Oleic acid |
| OR | Odds ratio |
| PG | Prostaglandin |
| PPAR-γ | Peroxisome proliferator-activated receptor γ |
| PUFAs | Polyunsaturated fatty acids |
| RBC | Red blood cell |
| SNPs | Single nucleotide polymorphisms |
| SPM | Specialised pro-resolving mediator |
| TLRs | Toll-like receptors |
| TNFα | Tumor necrosis factor α |
| TX | Thromboxane |
| UC | Ulcerative colitis |
| VCAM-1 | Vascular cell adhesion molecule 1 |